Peter C. Farrell's Insider Trades & SAST Disclosures
Peter C. Farrell's most recent trade in Resmed Inc. was a trade of 2,000 ResMed Common Stock done at an average price of $242.3 . Disclosure was reported to the exchange on May 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter C. Farrell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 242.25 per share. | 07 May 2025 | 2,000 | 71,218 (0%) | 0% | 242.3 | 484,500 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 219.74 per share. | 02 Apr 2025 | 2,000 | 73,218 (0%) | 0% | 219.7 | 439,480 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 227.71 per share. | 05 Mar 2025 | 2,000 | 75,218 (0%) | 0% | 227.7 | 455,420 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 242.11 per share. | 05 Feb 2025 | 2,000 | 77,218 (0%) | 0% | 242.1 | 484,220 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 230.99 per share. | 02 Jan 2025 | 2,000 | 79,218 (0%) | 0% | 231.0 | 461,980 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 245.65 per share. | 04 Dec 2024 | 2,000 | 81,218 (0%) | 0% | 245.7 | 491,300 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 1,468 | 1,468 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 542 | 83,218 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.81 per share. | 11 Nov 2024 | 527 | 82,676 (0%) | 0% | 252.8 | 133,233 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 248.74 per share. | 06 Nov 2024 | 2,000 | 83,204 (0%) | 0% | 248.7 | 497,480 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 237.20 per share. | 02 Oct 2024 | 2,000 | 85,204 (0%) | 0% | 237.2 | 474,400 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 239.90 per share. | 04 Sep 2024 | 2,000 | 87,204 (0%) | 0% | 239.9 | 479,800 | ResMed Common Stock |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 0 | - | - | Deferred Stock Units | |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 55,741 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 68,200 | 89,204 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 1,768 | 180,939 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.77 per share. | 13 Nov 2023 | 325 | 179,171 (0%) | 0% | 143.8 | 46,724 | ResMed Common Stock |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 11,869 | 11,869 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 3,131 | 3,131 | - | - | Deferred Stock Units | |
| Resmed Inc. | C. Peter Farrell | Director | Sale of securities on an exchange or to another person at price $ 237.17 per share. | 03 May 2023 | 12,600 | 166,896 (0%) | 0% | 237.2 | 2,988,375 | ResMed Common Stock |
| Resmed Inc. | Peter Farrell C. | Director | Sale of securities on an exchange or to another person at price $ 182.66 per share. | 03 May 2023 | 10,935 | 157,404 (0%) | 0% | 182.7 | 1,997,434 | ResMed Common Stock |
| Evolus Inc | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 11,789 | 11,789 | - | - | Stock Option (Right to Buy) | |
| Evolus Inc | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 8,293 | 43,174 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2022 | 1,122 | 179,496 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.18 per share. | 11 Nov 2022 | 128 | 178,374 (0%) | 0% | 225.2 | 28,823 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Sale of securities on an exchange or to another person at price $ 221.98 per share. | 31 Oct 2022 | 9,050 | 183,052 (0%) | 0% | 222.0 | 2,008,877 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2022 | 4,550 | 178,502 (0%) | 0% | 0 | ResMed Common Stock | |
| Evolus Inc | Peter C. Farrell | Director | Purchase of securities on an exchange or from another person at price $ 9.10 per share. | 06 Sep 2022 | 10,000 | 10,000 (0%) | 0% | 9.1 | 91,048 | Common Stock |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Evolus Inc | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 22,727 | 22,727 | - | - | Stock Option (Right to Buy) | |
| Evolus Inc | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 15,568 | 34,881 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2021 | 1,695 | 1,695 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2021 | 478 | 192,102 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.47 per share. | 11 Nov 2021 | 342 | 191,624 (0%) | 0% | 259.5 | 88,739 | ResMed Common Stock |
| Resmed Inc. | Peter C. Farrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2021 | 36,670 | 191,966 (0%) | 0% | 0 | ResMed Common Stock | |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Evolus Inc | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 19,313 | 19,313 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 1,187 | 228,636 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Peter C. Farrell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 579 | 227,449 (0%) | 0% | 212.1 | 122,812 | ResMed Common Stock |
| Arcturus Therapeutics Hold... | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges